Exam Details

Subject regulatory affairs - i
Paper
Exam / Course m.pharm
Department
Organization Gujarat Technological University
Position
Exam Date May, 2018
City, State gujarat, ahmedabad


Question Paper

Seat No.: Enrolment No.
GUJARAT TECHNOLOGICAL UNIVERSITY
M. Ph.- SEMESTER-II • EXAMINATION SUMMER -2018
Subject Code:MPT204T Date: 21/05/2018
Subject Name: Regulatory Requirements for Pharmaceutical Manufacturing
Time: 10:30 AM TO 01:30 PM Total Marks: 80
Instructions:
1. Attempt any five questions.
2. Make suitable assumptions wherever necessary.
3. Figures to the right indicate full marks.
Q.1

Describe principles of QbD as per ICH.
06

Write advantages, limitations and key elements of QbD in detail.
05

Explain QTPP and CQA as per ICH.
05
Q.2

Write objectives of Pharmaceutical development and discuss components of the drug products.
06

Discuss in detail about submission of Pharmaceutical development and related information as per CTD format.
05

Write an overview on "Optimization techniques in Pharmaceutical formulation and processing".
05
Q.3

Discuss in general about Quality Risk Management process.
06

What is Quality with respect to Pharmaceuticals? Write scope and principles of Quality Risk Management.
05

Explain HACCP and FMEA in detail.
05
Q.4

Write scope, objectives and Continual Improvements of the Pharmaceutical Quality Management System as per ICH Q10.
06

Discuss QbD approach as per ICH.
05

Explain in detail about Components and purpose of Experimental Design.
05
Q.5

Discuss QbD control strategy for Immediate Release and Modified Release dosage forms.
06

Explain Risk Assessment of Drug Product manufacturing process for modified release dosage forms.
05

Discuss Management responsibilities in PQM.
05
Q. 6

Write details on PAT Framework PAT Tools
06

Discuss examples of PAT implementation in detail.
05

Explain Risk Assessment of the Tablet compression process variables for Immediate release dosage forms.
05
Q.7

Write a short note on "QbD Implementation An FDA Perspective"
06

Highlight brief review on QRM tools.
05

Explain Implications Benefits of ICH in the Drug Development Cycle.
05



Subjects

  • advanced medicinal chemistry
  • advanced organic chemistry-i
  • advanced organic chemistry-ii
  • advanced pharmacology ii
  • advanced pharmacology-i
  • advances in drug delivery system
  • advances in pharmacology
  • applied pharmacotherapeutics - ii
  • applied pharmacotherapeutics-i
  • audits and regulatory compliance
  • biological evaluations & clinical research
  • cellular and molecular pharmacology
  • clinical and hospital pharmacy
  • clinical pharmacy practice
  • clinical research and pharmacy practice
  • clinical research and regulatory affairs
  • clinical research regulations
  • cosmetic and cosmeceuticals
  • documentation and regulatory writing
  • drug design and discovery
  • drug regulation and regulatory authority
  • experimental design and patents
  • global regulatory requirements
  • gmp, glp and validation
  • good manufacturing and good laboratory practice
  • good manufacturing practice and process validation
  • good regulatory practices
  • hazards and safety management
  • industrial pharmacy practice
  • modern analytical techniques
  • modern pharmaceutical analysis
  • novel drug delivery system part-i
  • novel drug delivery system-ii
  • pharm. management -ii
  • pharmaceutical analysis ii
  • pharmaceutical and cosmetic analysis
  • pharmaceutical formulation and development
  • pharmaceutical formulation development and biopharmceutics
  • pharmaceutical manufacturing technology
  • pharmaceutical production management & technology
  • pharmaceutical regulatory affairs
  • pharmacological and toxicological screening methods-i
  • pharmacological and toxicological screening methods-ii
  • pharmacometrics and methods of biological evaluation of drugs
  • pharmacotherapeutics
  • principles of biopharmaceutics& pharmacokinetics
  • product development and technology transfer
  • quality control & quality assurance
  • quality control and quality assurance
  • quality management system
  • regulatory affairs - i
  • regulatory affairs and new drug applications
  • regulatory aspects of hebbal and biologicals
  • research methodology
  • validation and product development